Zn(ii)-driven impact of monomeric transthyretin on amyloid-β amyloidogenesis
Yelim Yi, Bokyung Kim, Mingeun Kim, Young Ho Ko, Jin Hae Kim*, Mi Hee Lim*
Chem. Sci., 2025
2
Insights into an indolicidin‐derived low‐toxic anti‐microbial peptide's efficacy against bacterial cells while preserving eukaryotic cell viability
Jihyun Kim, Jieun Lee, Eunho Kang, Kyoungmin Lee, Kyungeun Lee, Yeongmi Cheon, Seongsoo Lee, Bokyung Kim, Young Ho Ko, Jin Hae Kim, Su Il In, Chang Hoon Nam
Biofactors, 2025
3
Thyroxine metabolite-derived 3-iodothyronamine (T1AM) and synthetic analogs as efficient suppressors of transthyretin amyloidosis
Bokyung Kim, Young Ho Ko, Jinbeom Si, Jongbum Na, Gabriella Ortore*, Grazia Chiellini*, Jin Hae Kim*
Comput. Struct. Biotechnol. J., 2023
4
Contagious Aggregation: Transmittable Protein Aggregation in Cellular Communities Initiated by Synthetic Cells
Hong-Guen Lee, Jin Hae Kim, Tumpa Gorai, Young Ho Ko, Haw-Young Kwon, Wooseong Chung, Ilha Hwang, Sungsu Lim, Yun Kyung Kim, Kwanwoo Shin, Young-Tae Chang*, Kimoon Kim*, Kyeng Min Park*
J. Am. Chem. Soc., 2022
5
Aggregation-prone structural ensembles of transthyretin collected with regression analysis for NMR chemical shift
Wonjin Yang, Beom Soo Kim, Srinivasan Muniyappan, Young-Ho Lee, Jin Hae Kim*, Wookyung Yu*
Front. Mol. Biosci., 2021
6
Facile and versatile ligand analysis method of colloidal quantum dot
Jin Hae Kim*, Hyokeun Park, Tae-Gon Kim, Hyunmi Lee, Shinae Jun, Eunha Lee, Woo Sung Jeon, Jaegwan Chung, In-Sun Jung*
Sci. Rep., 2021
7
17O NMR Spectroscopy: A Novel Probe for Characterizing Protein Structure and Folding
Srinivasan Muniyappan, Yuxi Lin, Young Ho Lee, Jin Hae Kim
Biology (Basel), 2021
8
Transthyretin misfolding, a fatal structural pathogenesis mechanism
Jin-Beom Si, Bokyung Kim, Jin Hae Kim
Int. J. Mol. Sci., 2021
9
Diphenyl-methane based thyromimetic inhibitors for transthyretin amyloidosis
Bokyung Kim, Young Ho Ko, Massimiliano Runfola, Simona Rapposelli, Gabriella Ortore*, Grazia Chiellini*, Jin Hae Kim*
Int. J. Mol. Sci., 2021
10
Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer’s Disease?